(a) |
KEGG Pathway |
p-Value |
Number of Genes Involved |
Number of miRNAs Involved |
Prion diseases |
4.07 × 10−10
|
7 |
7 |
Morphine addiction |
4.80 × 10−5
|
32 |
17 |
Amino sugar and nucleotide sugar metabolism |
0.002142 |
16 |
11 |
Thyroid hormone signaling pathway |
0.002958 |
37 |
17 |
Cell adhesion molecules (CAMs) |
0.006179 |
43 |
16 |
Endocytosis |
0.009192 |
63 |
18 |
Oxytocin signaling pathway |
0.011941 |
53 |
21 |
Melanogenesis |
0.013774 |
35 |
17 |
MAPK signaling pathway |
0.013774 |
77 |
22 |
GABAergic synapse |
0.02274 |
32 |
18 |
Vasopressin-regulated water reabsorption |
0.035605 |
16 |
11 |
Adrenergic signaling in cardiomyocytes |
0.035605 |
48 |
22 |
Glutamatergic synapse |
0.03746 |
34 |
13 |
Biosynthesis of unsaturated fatty acids |
0.040121 |
7 |
5 |
Circadian entrainment |
0.046058 |
37 |
16 |
(b) |
KEGG Pathway |
p-Value |
Number of Genes Involved |
Number of miRNAs Involved |
Mucin type O-Glycan biosynthesis |
1.69 × 10−11
|
11 |
7 |
Fatty acid biosynthesis |
1.86 × 10−8
|
1 |
1 |
Glycosphingolipid biosynthesis-lacto and neolacto series |
6.27 × 10−5
|
9 |
8 |
Fatty acid metabolism |
0.000184 |
7 |
6 |
Adherens junction |
0.000623 |
25 |
18 |
Biotin metabolism |
0.010804 |
1 |
1 |
Arrhythmogenic right ventricular cardiomyopathy |
0.014001 |
21 |
18 |
Caffeine metabolism |
0.027365 |
2 |
2 |
Thyroid hormone signaling pathway |
0.027365 |
32 |
21 |